EGF Theramed Health (TMED)

EGF Theramed Health Company Information

EGF Theramed Health is a medical science consumer technology company specializing in developing diagnostic tools, products, and technologies that facilitate individualized medical care. These technologies are applicable in various medical areas, including heart disease, skincare, and weight loss. 

The company’s current focus is on psychedelics, specifically psilocybin. It seeks to improve the compound’s delivery system while still creating a vast collection of intellectual properties for itself. 

EGF Theramed Health was incorporated in 2011. Up until 2019, it was known as Theramed Health Corp. 

EGF Theramed Health’s Mission 

Mental health conditions are prevalent worldwide, and through research, psychedelics are gradually gaining recognition as a viable treatment option. 

The brand’s mission is to explore every available opportunity to form partnerships with pioneer brands by positioning itself as a frontier in the medical science industry. 

Investment in psychedelics research companies 

Pharmadelic Labs

This brand is involved in the biosynthesis of psilocybin and other compounds. Psilocybin is the psychedelic compound derived from magic mushrooms. EGF Theramed Health owns 30% of Pharmadelic labs from 6th May 2020. 

In preparation for the pending increased demand for psilocybin, Phamadelic labs focuses on producing psilocybin at a higher rate by advancing the biosynthesis pathways. With these pathways, the compound will be grown in several days. The traditional methods of growing psilocybin take weeks.

Green Parrot Labs

EGF Theramed Health owns 40% of Green Parrot Labs as of 22nd May 2020. Green Parrot Labs’ primary focus is conducting extensive research on psilocybin and its benefits. It looks into the compound’s biosynthesis and optimization. 

The company is strategically located in the Caribbean (Jamaica and the British Virgin Islands), where the laws are magic mushroom-friendly. The mushrooms also grow naturally in the area. 

The second focus is on opening new health centers that deal with a myriad of conditions. For example, the brand has a proprietary treatment that has clinically shown great potential in managing irritable bowel disease-related symptoms. 

Seedadelic Med Corp

On 14th December 2020, EGF Theramed Health signed a letter of intent to purchase fifteen million shares of Seedadelic Med Corp. Each common share is worth $0.115, meaning the deal totals $1,725,000. The sale will give EGF Theramed Health full ownership of the company. 

Seedadelic Med Corp deals with LSA and other related psychedelics. It seeks to eradicate pharmaceutical dependence by offering patients a natural, safer, and effective alternative.